BUY HEPATITIS C MEDICINE FROM INDIA

Marketed Natco

Indian Brand – Hepcinat Plus Tablets

Active Ingredient(s) – Sofosbuvir And Daclatasvir Diydrochloride Tablets

Strength – 400mg and 60mg

Dosage Form – Tablet

Package Size – 28 Tabs

Package Type – Plastic Bottle

Expiry – 1 Year to 2 Years

Indication(s) – Hepatitic C Virus (HCV) Infection

Hepcinat Plus tablet is an antiviral medication. It works by lowering a load of hepatitis C virus in the body and removing the virus from the blood over a period of time. These medications together reduce the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer.

 

The dosage should be determined by the doctor based on your age, overall medical history and current condition. The usual dose in adults for treating chronic hepatitis C is 60 mg, taken orally once daily for a period of 12 weeks.

Sofokast plus tablets, which contain 400 mg Sofosbuvir is a nucleotide polymerase inhibitor, and includes antiviral drugs direct action. sofosbuvir is exposed to have a high barrier to growth resistance and inhibits the Cb NS5B Hep protein. Thus, Sofosbuvir interferes with the enzyme RNA polymerase by a cell worker who can perform the reproduction process. Consequently, Sofosbuvir stops hepatitis C virus replication and reduces the amount of Hep C virus in the liver. Sofosbuvir also acts to reduce liver damage and improve liver function.

Sofokast plus tablets also contains daclatasvir, a direct-acting antiviral drug that is indicated for a patient affected by hepatitis C virus infection. It will target the Hep C virus and stops numerous steps in the HCV reproduction process by preventing viral particles from making copies themselves, and helps the body remove the virus from the blood.

Velpanat (Sofosbuvir 400 mg + Velpatasvir 100 mg) is a combinational anti-Hepatitis C drug used in patients with genotype 1 to 6. The combined inhibitory action of Sofosbuvir 400 mg and Velpatasvir 100 mg, allows 93-99% of overall response rate against HCV cells.

The dosage of Velpanat consists of 400 mg of sofosbuvir and 100 mg of velpatasvir combined in a single tablet. The tablet is taken orally once daily with or without food. In situations where the patients are at higher risk of liver disease, ribavirin is also added for a constant response.

Velpanat (Sofosbuvir + Velpatasvir) has one of the highest sustained viral response (SVR) amongst combined anti-HCV agents. However, the SVR differs based on the type of liver disease associated with HCV.

With our in-depth knowledge and rich industry experience in this field, we are highly engaged in exporting, retailing, wholesaling and supplying a qualitative VIRPAS Tablet for our esteemed clients. Processed employing advanced technology and using premium quality chemical compounds, offered tablet should only be used under proper medical guidance and advice. In order to maintain the effectiveness, our quality examiners test this tablet on various parameters.

Features:

• Highly effective
• Long shelf life
• Balanced composition

 

Other Details: 28 Tablets.

With our in-depth knowledge and rich industry experience in this field, we are highly engaged in exporting, retailing, wholesaling and supplying a qualitative Hepcinat-Lp Tablet for our esteemed clients. Processed employing advanced technology and using premium quality chemical compounds, offered tablet should only be used under proper medical guidance and advice. In order to maintain the effectiveness, our quality examiners test this tablet on various parameters.

Features:

• Highly effective
• Long shelf life
• Balanced composition

 

Other Details: 28 Tablets.

Other Details:

• Dacihep is a prescription drug and should be used under proper medical guidance and advice
• The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers
• Keep all medicines out of the reach of children and away from pets,never share your medicines with others,and use this medication only for the indication prescribed

To meet the diverse demands of our precious clients, we are engaged in exporting, retailing and wholesaling an optimum quality Hepcinat Tablet. The offered tablet is used to cure people of the Hep C virus along with combination of other medications. To process this tablet, our vendors’ professionals use only high grade chemical compounds and the latest technology in sync with predefined industry quality norms. Apart from this, offered tablet is available in different packaging options as per the needs of our clients.

Features:

• Accurate composition
• Hygienically packed
• Effectiveness

Other Details: 28 Tablets.

• Item Code: 400mg
• Delivery Time: 10 to 14 days

MyHep contains the active ingredient Sofosbuvir. It is a generic brand of anti-viral medication used to treat Hepatitis C virus. MyHep is manufactured by Mylan Pharmaceuticals. Sofosbuvir can help the immune system and the liver recover from a Hepatitis C infection.

Specifications:

• Active Ingredients: Sofosbuvir
• Manufacturer: Mylan
• Use: In liver infection

MOQ 28 Tab

DESCRIPTION

Dacikast 60mg (Daclatasvir) is an inhibitor of non-structural protein 5A (NS5A). Each film-coated tablet contains Daclatasvir Dihydrochloride equivalent to Daclatasvir 30 mg or 60mg. Empirical formula for Daclatasvir Dihydrochloride is C40H50N8 O6. 2HCl. Daclatasvir is white to yellow colour solid and freely soluble in water. The tablets include the following inactive ingredients: Anhydrous Lactose, Microcrystalline cellulose, Croscarmellose sodium, Colloidal silicon dioxide, Magnesium stearate, Opadry Orange

Mechanism of Action

 

Dasikast Tablets Daclatasvir 60mg is an inhibitor of nonstructural protein 5A (NS5A), a multifunctional protein that is an essential component of the HCV replication complex. Daclatasvir inhibits both viral RNA replication and virion assembly.

Pharmacokinetics

The pharmacokinetic properties of Dasikast (Daclatasvir) were evaluated in healthy adult subjects and in patients with chronic HCV. Following multiple oral doses of Daclatasvir 60 mg once daily in combination with peg interferon alfa and ribavirin in treatment naive patients with genotype 1 chronic HCV, the geometric mean (CV%) Daclatasvir Cmax was 1534 (58) ng/ml, AUC0-24h was 14122 (70) ng*h/ml, and Cmin was 232 (83) ng/ml.

INDICATIONS AND USAGE

Dacikast is indicated in combination with Sofosbuvir for the treatment of patient with chronic hepatitis C virus (HCV) genotype 3 infection.

DOSAGE AND ADMINISTRATION

 

Treatment with Dacikast should be initiated and monitored by a physician experienced in the management of chronic hepatitis C. The recommended dose of Dacikast is 60 mg once daily, to be taken orally with or without meals. Dacikast must be administered in combination with other medicinal products. The Package Inserts of the other medicinal products in the regimen should also be consulted before initiation of therapy with Dacikast. Recommended regimens and treatment duration are provided in Table 1

CONTRAINDICATIONS

 

Hypersensitivity to the active substance or to any of the Excipients Co-administration with medicinal products that strongly induce cytochrome P450 3A4 (CYP3A4) and P-glycoprotein transporter (P-gp) and thus may lead to lower exposure and loss of efficacy of Daclatasvir. These active substances include but are not limited to phonation, carbamazepine, oxcarbazepine, phenobarbital, rifampicin, rifabutin, rifapentine, systemic dexamethasone, and the herbal product St John’s wort (Hypericum perforatum).

OVERDOSAGE

There is limited experience of accidental overdose of Daclatasvir in clinical trials. In phase 1 clinical trials, healthy subjects who received up to 100 mg once daily for up to 14 days or single doses up to 200 mg had no unexpected adverse reactions. There is no known antidote for overdose of Daclatasvir. Treatment of overdose with Daclatasvir should consist of general supportive measures, including monitoring of vital signs, and observation of the patient’s clinical status. Because Daclatasvir is highly protein bound (99%) and has a molecular weight >500, dialysis is unlikely to significantly reduce plasma concentrations of Daclatasvir

HOW SUPPLIED AND STORAGE

 

Dacikast 30 mg tablets are available in bottle pack of 28 tablets. Dacikast 60 mg tablets are available in bottle pack of 28 tablets. Store below 25°C. 

• Delivery Time: 1 To 2 Days

Why is this medication prescribed?

Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors. It works by stopping the virus that causes hepatitis C from spreading inside the body. It is not known if daclatasvir prevents the spread of hepatitis C to other people.

How should this medicine be used?

Daclatasvir comes as a tablet to take by mouth. It is usually taken with or without food once a day. Daclatasvir must be taken in combination with sofosbuvir, usually for 12 weeks. Take daclatasvir at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take daclatasvir exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Continue to take daclatasvir even if you feel well. Do not stop taking daclatasvir or sofosbuvir without talking to your doctor.

Ask your pharmacist or doctor for a copy of the manufacturer’s information for the patient.

Other uses for this medicine

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information

• Delivery Time: 10 To 14 Days

WHAT IS MYHEP ALL ?

MyHep All medication is a combination of sofosbuvir and velpatasvir. This drug work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover

MEDICINE USES :

MyLan Pharmaceutical Sofosbuvir and Velpatasvir is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication (ribavirin).

SOFOSBUVIR VELPATASVIR COMMON SIDE EFFECTS :

Common MyHep All side effects may include:

• headache;
• tired feeling;
• nausea, diarrhea; or
• sleep problems (insomnia)

 

WHAT IS HEPCVIR L ?

HEPCVIR L is a combination of two hepatitis C virus (HCV) antiviral drugs in a single form. Each single tablet contains ledipasvir and sofosbuvir.

USES :

HEPCVIR L is a combination of ledipasvir and sofosbuvir and is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication (ribavirin). These drugs work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover.

HEPCVIR L COMMON SIDE EFFECTS :

Tiredness, headache, nausea, diarrhea, or difficulty sleeping may occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.

A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.

This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.

SAFETY INFORMATION (Precautions) :

• Before taking ledipasvir/sofosbuvir, tell your doctor or pharmacist if you are allergic to either of the drugs; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.
• Before using this medication, tell your doctor or pharmacist your medical history, especially of: kidney disease.

• Delivery Time: 7 to 14 Days

Velpatasvir Sofosbuvir ( Tab Velasof ) by Hetero is a combination of sofosbuvir and velpatasvir and is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It is also used with another antiviral medication (ribavirin). These drugs work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover.

Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer.

Sofosbuvir 400 mg Velpatasvir 100 mg Indication :

Velasof ( Sofosbuvir 400 mg velpatasvir 100 mg) is used alone or with ribavirin to treat chronic hepatitis C. Sofosbuvir is in a class of antiviral medications called nucleotide hepatitis C virus (HCV) NS5B polymerase inhibitors. Velpatasvir is in a class of antiviral medications called HCV NS5A replication complex inhibitors.

The combination of sofosbuvir and velpatasvir works by stopping the virus that causes hepatitis C from spreading inside the body.

• Delivery Time: 7 to 14 days

Indication:

Sofosbuvir With Velpatasvir is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir, a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection.

Mechanism of action:

Sofosbuvir With Velpatasvir is an oral fixed-dose combination of sofosbuvir, a nucleotide analog NS5B polymerase inhibitor and velapatasvir, an NS5A replication complex inhibitor. Sofosbuvir is approved for the treatment of genotype 1, 2, 3 and 4 HCV infection with different regimens and durations dependent on the HCV genotype. Velpatasvir (formerly GS-5816) is a novel NS5A inhibitor that has potent invitro anti-HCV activity across all genotypes at the picomolar level. The combination of sofosbuvir-velpatasvir is the first once-daily single-tablet regimen with pangenotypic activity.

Dosage and Administration:

Sofosbuvir With Velpatasvir is available as a coformulated, once-daily single-pill combination of sofosbuvir 400 mg and velpatasvir 100 mg. The recommended dose is one tablet once daily, taken with or without food.

• Renal Impairment: For patients with mild to moderate renal impairment, no dosage adjustment of sofosbuvir-velpatasvir is recommended. There are insufficient data regarding the safety and efficacy of sofosbuvir-velpatasvir in patients with severe renal impairment (eGFR less than 30 ml/min/1.73m2) or end-stage renal disease requiring hemodialysis. Accordingly, no dosage recommendation has been given for patients with severe renal impairment or end-stage renal disease requiring dialysis.
• Hepatic Impairment: For patients with mild, moderate, or severe hepatic impairment (Child-Pugh Class A, B, or C), no dosage adjustment for sofosbuvir-velpatasvir is recommended. For patients with decompensated cirrhosis who are receiving sofosbuvir-velpatasvir and ribavirin, clinical and laboratory monitoring is recommended.

Precaution:

Risk of Serious Symptomatic Bradycardia When Sofosbuvir Is Coadministered with Amiodarone and Another HCV Direct Acting Antiviral: Amiodarone is not recommended for use with Sofosbuvir With Velpatasvir due to the risk of symptomatic bradycardia, particularly in patients also taking beta blockers or with underlying cardiac comorbidities and/or with advanced liver disease. In patients without alternative, viable treatment options, cardiac monitoring is recommended. Patients should seek immediate medical evaluation if they develop signs or symptoms of bradycardia.

Risk of Reduced Therapeutic Effect Due to Concomitant Use of Sofosbuvir With Velpatasvir with P-gp Inducers and/or Moderate to Potent Inducers of CYP2B6, CYP2C8 or CYP3A4: Rifampin, St. Johns wort, and carbamazepine are not recommended for use with Sofosbuvir With Velpatasvir as they may significantly decrease sofosbuvir and/or velpatasvir plasma concentrations.

With our in-depth knowledge and rich industry experience in this field, we are highly engaged in exporting, retailing, wholesaling and supplying a qualitative NATDAC Tablet for our esteemed clients. Processed employing advanced technology and using premium quality chemical compounds, offered tablet should only be used under proper medical guidance and advice. In order to maintain the effectiveness, our quality examiners test this tablet on various parameters.

Features:

• Highly effective
• Long shelf life
• Balanced composition

 

Other Details: 28 Tablets.

• Delivery Time: 7 to 14 days

UsesCimivir 400mg tablet is used in the treatment of chronic hepatitis CHow it worksCimivir 400mg tablet is an antiviral drug that belongs to a class of medicines called nucleotide polymerase inhibitors. It inhibits an enzyme RNA polymerase which is essential for viral replication and thus decreases the amount of Hepatitis C virus in the body thereby resulting in less liver damage and improved liver function.Common side effects Nausea, Pale colored skin, Back pain, Chills, Diarrhoea, Fatigue, Weakness, Fever, Headache, Insomnia, Loss of appetite, Mouth ulcer, Muscle pain, Muscle cramp, Rash, Itching, Sores, Ulcer

MOQ 28 Tab

WHAT IS RESOF TOTAL?
Resof Total medication is a combination of sofosbuvir and velpatasvir. This drug work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover.

MEDICINE USES :
Dr. Reddy’s Laboratories Limited Sofosbuvir and Velpatasvir is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication (ribavirin).

SOFOSBUVIR VELPATASVIR COMMON SIDE EFFECTS :
Common Resof Total side effects may include:

headache;
tired feeling;
nausea, diarrhea; or
sleep problems (insomnia).
Call your doctor at once if you have:

slow heartbeats;
weak or shallow breathing; or
low red blood cells-pale skin, weakness, rapid heart rate, trouble concentrating.
If you also take amiodarone: Seek medical help right away if you feel weak, tired, or light-headed, or if you have chest pain, shortness of breath, confusion, or memory problems.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

Brand Name : Resof Total
Active Ingredients : Sofosbuvir Velpatasvir
Marketed by : Dr. Reddy’s Laboratories Limited
Form : Tablets
Strength : Sofosbuvir 400mg and Velpatasvir 100mg
Packing : Pack of 28 Tablets

Other Details:

• Ledifos Tablets contains Ledipasvir and Sofosbuvir a formulation combination of anti-viral medications used in the treatment of Chronic Hepatitis C Virus (CHC) infection genotype 1
• Ledifos is a prescription medicine containing Ledipasvir (90mg) a viral NS5A inhibitor and Sofosbuvir (400mg) a nucleotide inhibitor of the viral RNA polymerase

• Delivery Time: 7 to 14 Days

We are extremely engrossed in exporting, retailing, wholesaling and supplying a premium quality DACLACURE Tablet. The offered tablet is processed utilizing superior quality chemical compounds and the latest technology in compliance with industry norms. The offered tablet when used in combination with sofosbuvir may result in slowing of the heart rate. Apart from this, we offer this tablet in various packaging options so as to maintain its long shelf life.

Features:

• 100% safe
• Safe to consume
• Free from impurities

Other Details: 28 Tablets

 

Other Details:

• SoviHep (Sofosbuvir) which is a drug used as part of antiviral therapy against chronic hepatitis C virus, this drug is directly targets the Hep C virus to stop it from making copies of itself in the liver and makes it harder for the virus to multiply
• SoviHep (Sofosbuvir) must be used in combination with other HCV medications such as Pegylated and Ribavirin

• Delivery Time: 7 to 14 days

Other Details:

• Ledihep is a prescription drug and should be used under proper medical guidance and advice
• The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers

We are extremely engaged in offering an incomparable quality Sofovir Tablet. Directly targets the hepatitis c virus to stop it from making copies of itself in the liver and makes it harder for the virus to multiply, offered tablet is processed under guidance of vendor professionals using the best quality chemical compounds and cutting edge technology. So as to offer a qualitative product, this tablet is rigorously tested on different parameters of quality. Apart from this, we provide this tablet in various packaging options so as to maintain its quality.

Features:

• Temper proof packing
• No side effects
• Safe packaging

Other Details: 7 Tablets.

• Delivery Time: 10 to 14 days

We have achieved a distinct position in the market by wholesaling and exporting a superior quality Hepcvir Tablet. Used in combination with other antiviral medicines to reduce the amount of hepatitis C virus (HCV) in the body to help the liver recover, offered tablet is hygienically processed using the best quality chemical compounds and modern technology under the vigilance of vendors’ professionals in line with set industry standards. Furthermore, this tablet is tested on varied parameters by our quality examiners so as to ensure its quality.

Features:

• Accurate composition
• Highly effective
• No side effects

Other Details: 15 Tablets.

• Delivery Time: 7 To 14 Days

Uses Viroclear 400mg tablet is used in the treatment of chronic hepatitis C How it works Viroclear 400mg tablet is an antiviral drug that belongs to a class of medicines called nucleotide polymerase inhibitors. It inhibits an enzyme RNA polymerase which is essential for viral replication and thus decreases the amount of Hepatitis C virus in the body thereby resulting in less liver damage and improved liver function.Common side effects Nausea, Pale colored skin, Back pain, Chills, Diarrhoea, Fatigue, Weakness, Fever, Headache, Insomnia, Loss of appetite, Mouth ulcer, Muscle pain, Muscle cramp, Rash, Itching, Sores, Ulcer

Ledipasvir(90mg)Uses
Common side effects Sofosbuvir(400mg)Uses Sofosbuvir is used in the treatment of chronic hepatitis cHow it works Sofosbuvir is an antiviral drug that belongs to a class of medicines called nucleotide polymerase inhibitors. It inhibits an enzyme RNA polymerase which is essential for viral replication and thus decreases the amount of Hepatitis C virus in the body thereby resulting in less liver damage and improved liver function.Common side effects Nausea, Pale colored skin, Back pain, Chills, Diarrhoea, Fatigue, Weakness, Fever, Headache, Insomnia, Loss of appetite, Mouth ulcer, Muscle pain, Muscle cramp, Rash, Itching, Sores, Ulcer

We are extremely engrossed in exporting, retailing, wholesaling and supplying a premium quality Daclahep Tablet. The offered tablet is processed utilizing superior quality chemical compounds and the latest technology in compliance with industry norms. The offered tablet when used in combination with sofosbuvir may result in slowing of the heart rate. Apart from this, we offer this tablet in various packaging options so as to maintain its long shelf life.

Features:

• 100% safe
• Safe to consume
• Free from impurities

Other Details: 28 Tablet

• Delivery Time: 10 to 14 days

Sofosbuvir(400 Mg)Uses Resof 400mg tablet is used in combination with other antiviral drugs for treatment of patients with viral infection that damages the liver (Hepatitis C) including those patients who have human immunodeficiency virus (HIV) infection or liver cancer or are awaiting a liver transplant.How it works Resof 400mg tablet is an antiviral drug that belongs to a class of medicines called nucleotide polymerase inhibitors. It inhibits an enzyme RNA polymerase which is essential for viral replication and thus decreases the amount of Hepatitis C virus in the body thereby resulting in less liver damage and improved liver function.Common side effectsNausea, Pale colored skin, Back pain, Chills, Diarrhoea, Fatigue, Weakness, Fever, Headache, Insomnia, Loss of appetite, Mouth ulcer, Muscle pain, Muscle cramp, Rash, Itching, Sores, Ulcer

• Delivery Time: 10 TO 14 DAYS